On October 9, 2017, Popular Science featured a range of AFAR experts in an article on the varied opinions in the field of aging research on strategies to extend healthspan and longevity.
The provocatively titled piece “Is Living Forever Going to Suck,” spotlights:
The article also discusses the AFAR-managed TAME (Targeting Aging with Metformin) Trial.
After surveying the potential for interventions to move into clinical trials, the article ends with optimism of the progress the field has made, quoting James L. Kirkland, MD, PhD:
“20 years ago, I would have said [finding a way to extend the health span] had a .5 percent chance of working. It’s up to a 25 percent chance now, and every year it’s going up,” Kirkland says.
Read the full article here.
Luigi Fontana, MD, PhD, is the Co-Director of the Longevity Institute and Professor, Geriatrics & Nutritional Science at Washington University in St. Louis
Derek Huffman, PhD, is an Assistant Professor, Albert Einstein College of Medicine
Gordon Lithgow, PhD, is a Professor at the Buck Institute for Research on Aging
Matthew Kaeberlein, PhD, is a director at the University of Washington Medicine Nathan Shock Center of Excellence in the Basic Biology of Aging; Director, Healthy Aging and Longevity Research Institute; and President, American Aging Association
James L. Kirkland, MD, PhD, is the Director of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic.
